Cardinal Health (CAH) Business News

Track Cardinal Health in real time with a live news feed covering Cardinal Health stock news, official press releases, company announcements, and an archive of historical Cardinal Health news. ...more

  • Calendar
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
news photo
Loading...

Research confirms advanced therapies are moving beyond inpatient hospitals, with providers increasingly supporting partnerships that bring life-changing treatments closer to patients' homes. DUBLIN, Ohio, April 14, 2026 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2026 Advanced Therapies Report: Perspectives on Community Expansion, offering new insights into how the expanding advanced therapy pipeline is reshaping sites of care.

Read full article redirect
7:00 AM | Tuesday | Apr 14, 2026

Cardinal Health report highlights growing momentum to expand advanced therapies into community care settings

PRNewsWire

Research confirms advanced therapies are moving beyond inpatient hospitals, with providers increasingly supporting partnerships that bring life-changing treatments closer to patients' homes. DUBLIN, Ohio, April 14, 2026 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2026 Advanced Therapies Report: Perspectives on Community Expansion, offering new insights into how the expanding advanced therapy pipeline is reshaping sites of care.

Read full article arrow
News Thumbnail
12:26 PM | Wednesday | Apr 8, 2026

Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now

Zacks Investment Research

CAH's specialty growth, strong pharma demand and expanding services portfolio are driving earnings momentum and positioning it for sustained long-term growth.

Read full article arrow
News Thumbnail
10:42 AM | Tuesday | Apr 7, 2026

Is Cardinal Health (CAH) Stock Undervalued Right Now?

Zacks Investment Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read full article arrow
News Thumbnail
10:40 AM | Monday | Apr 6, 2026

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term

Zacks Investment Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read full article arrow
News Thumbnail
5:34 AM | Friday | Apr 3, 2026

4,000 Shares in Cardinal Health, Inc. $CAH Purchased by FNY Investment Advisers LLC

Defense World

FNY Investment Advisers LLC bought a new stake in shares of Cardinal Health, Inc. (NYSE: CAH) during the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund bought 4,000 shares of the company's stock, valued at approximately $822,000. Other hedge funds have also made changes to

Read full article arrow
News Thumbnail
1:45 PM | Thursday | Apr 2, 2026

Cardinal Health Expands Ac-225 Capacity to Boost Cancer Therapies

Zacks Investment Research

CAH expands Ac-225 capacity, boosting its role in radiopharma as rising clinical demand and future cancer therapy commercialization drive growth.

Read full article arrow
News Thumbnail
11:30 AM | Wednesday | Apr 1, 2026

Can CAH's Specialty Flywheel Strategy Unlock Long-Term Growth?

Zacks Investment Research

CAH's specialty flywheel strategy links distribution, MSOs and biopharma services, boosting partnerships, drug launches and recurring revenue potential.

Read full article arrow
News Thumbnail
7:00 AM | Wednesday | Apr 1, 2026

Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies

PRNewsWire

DUBLIN, Ohio, April 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced a significant expansion of its Actinium-225 (Ac-225) production capabilities at the company's Center for Theranostics Advancement (CTA) in Indianapolis, Indiana. The addition of a high-capacity production line to its Drug Master File (DMF) will substantially increase Cardinal Health's supply of cGMP-compliant Ac-225 for use in investigational therapeutic drug products and future commercial manufacturing novel therapies.

Read full article arrow
News Thumbnail
4:41 AM | Wednesday | Apr 1, 2026

Burns Matteson Capital Management LLC Boosts Holdings in Cardinal Health, Inc. $CAH

Defense World

Burns Matteson Capital Management LLC lifted its position in shares of Cardinal Health, Inc. (NYSE: CAH) by 182.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,403 shares of the company's stock after buying an additional 3,492 shares during the period.

Read full article arrow
News Thumbnail
7:01 PM | Tuesday | Mar 31, 2026

Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know

Zacks Investment Research

In the latest trading session, Cardinal Health (CAH) closed at $211.31, marking a +2.42% move from the previous day.

Read full article arrow
News Thumbnail